Form 8-K - Current report:
SEC Accession No. 0000950170-25-064475
Filing Date
2025-05-06
Accepted
2025-05-06 16:11:21
Documents
12
Period of Report
2025-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20250506.htm   iXBRL 8-K 55409
2 EX-99.1 lyra-ex99_1.htm EX-99.1 200785
  Complete submission text file 0000950170-25-064475.txt   385500

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20250506.xsd EX-101.SCH 26034
14 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20250506_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 25917375
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)